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Abstract
Eﬀects of short-term lyophilized beer (LB) consumption on normotensive (WKY) and hypertensive (SHR) rats are reported. It was
found that LB contains high quantities of bioactive compounds and has a high antioxidant potential. The WKY and SHR rats were
divided into four groups of 8, two experimental and two controls, which were named LBWKY and LBSHR and ControlWKY and Con-
trolSHR, respectively. LB was given to the rats of the LBWKY and LBSHR groups intragastrically at a dose of 2.72 g/kg in a volume of
10 ml/kg for 10 days. The rats of the control groups received saline solution. The following indices were determined: body weight gain,
heart rate, systolic blood pressure, using a tail cuﬀ method and GABA accumulation in the hypothalamus and the pons-medulla as mea-
sured by GABA-T inhibition. It was found that the treatment of rats with LB had no eﬀect on the blood pressure and heart rate values.
In both rat strains, LB decreased GABA accumulation in the hypothalamus and the pons-medulla.
A signiﬁcant reduction of body weight gain was observed in both LB-treated groups when compared with the corresponding controls.
In conclusion, LB contains high quantities of bioactive compounds and possesses a high antioxidant potential. Diet supplemented
with LB causes signiﬁcant reduction of the central GABAergic activity in WKY and SHR rats without any eﬀect on cardiovascular func-
tion. In addition, in both animal strains there was an apparent inverse association between LB intake and body weight gains.
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1. Introduction
In most Western countries alcohol beverages are an inte-
gral part of diets (Renaud and Lorgeril, 1992). Epidemio-
logical, experimental and clinical investigations show that
such diets, supplemented with various kinds of alcoholic
beverages have a cardioprotective eﬀect (Thun et al.,
1997; Gronbaek, 2006). Moderate consumption of alco-
holic beverages leads to cardioprotective eﬀects: decrease
in the plasma lipids levels and increase in the antioxidant
and anticoagulant activities both in laboratory animals
and humans (Renaud and Lorgeril, 1992; Gorinstein
et al., 1997a; Gorinstein et al., 1997b; Thun et al., 1997;
Klatsky, 2004; Mann and Folts, 2004; Gronbaek, 2006).
Contrary, some authors have shown that consumption of
alcoholic beverages increases blood pressure (Vandongen
and Puddey, 1994).
Until now, red wine has been the cardioprotective bever-
age of choice (Klatsky and Armstrong, 1993). But Innes,
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risk factors of the heart diseases. According to Innes, eﬀec-
tiveness, low cost, acceptable adverse-event proﬁle and sin-
gle-dose dispensers of beer are the basis for replacing red
wine as the cardioprotective beverage of coronary athero-
sclerosis in hypertensive patients. It was shown that moder-
ate wine drinkers have lower hypertension-related mortality
(Renaud et al., 2004). However, consumption of alcoholic
beverages has also adverse eﬀects (Marway et al., 1993;
Preedy et al., 1994). Therefore, lyophilized beverages are
successful used in experiments on laboratory animals and
investigations of humans: the level of the plasma lipids
was decreased and the plasma antioxidant activity increased
(Gorinstein et al., 1998a; Gorinstein et al., 1998b; Carbon-
neau et al., 1998; Seraﬁni et al., 1998). This positive inﬂu-
ence of lyophilized beverages is a results of their
biologically active compounds mainly phenolic compounds
(Carbonneau et al., 1998; Seraﬁni et al., 1998). Statistical
data show that coronary heart disease patients are often
suﬀering also from high blood pressure (Vandongen and
Puddey, 1994). Could moderate lyophilized beer consump-
tion inﬂuence the blood pressure as the mentioned cardio-
protective indices? In order to answer this question we
decided to assess the eﬀect of moderate dose of lyophilized
beer in experiment on normotensive and hypertensive rats.
In a convincing experiment, Uchida et al., 1989, have
found that tannin, a high molecular weight phenolic com-
pound, prolongs the lifespan of stroke-prone spontane-
ously hypertensive rats. However, there has been no
investigation done to assess whether the dry matter of alco-
holic beverages could positively inﬂuence the cardiovascu-
lar system function of normotensive and hypertensive rats.
Therefore, it was decided to perform such experiment.
The importance of the GABAergic mechanisms for the
regulation of cardiovascular system function has been well
established. Some investigators imply that the central
GABAergic system in SHR is impaired (Sasaki et al.,
1990). We attempted to clear up whether lyophilized beer
as a cardioprotective beverage of choice might improve
the disturbed GABAergic function in hypertension and
normalize blood circulation. In our experiments we decided
to use the lyophilized beer with a high content of phenolic
compounds with high antioxidant potential.
2. Materials and methods
2.1. Reagents
Trolox (6-hydroxy-2,5,7,8,-tetramethyl-chroman-2-carboxylic acid)
and 2,20-azino-bis (3-ethyl-benzothiazoline-6-sulfonic acid) diamonium
salt (ABTS) were purchased from Sigma Chemical Co (St. Louis, MO,
USA). All reagents were of analytical grade.
2.2. Beer samples
The Maccabee beer samples were produced by Tempo Beer Industries,
Natania, Israel. To receive alcohol free examples they were freeze-dried
and then analysed as previously described (Gorinstein et al., 1998a;
Gorinstein et al., 1998b).
2.3. Chemical analysis of beer samples
Proteins, albumins, glucose, maltose, maltotriose, and dextrins were
determined by conventional analyses. The determination of total poly-
phenols and beer antioxidant potential was done as follows:
(a) Total polyphenols were measured at 765 nm using Folin–Ciocalteu
reagent with gallic acid as a standard and were expressed as mg/g
of gallic acid equivalent (Singleton and Rossi, 1965).
(b) Total ﬂavonoids were determined by a colorimetric method. A
0.25 mL of beer was diluted with 1.25 mL of distilled water; then
75 lL of a 5% NaNO2 solution was added to the mixture. After
6 min, 150 lL of a 10% AlCl3 · 6H2O solution was added, and
the mixture was allowed to stand for another 5 min. A 0.5 mL quan-
tity of 1 mol/L NaOH was added, and the total was made up to
2.5 mL with distilled water. The solution was well mixed, and the
absorbance was measured immediately against the prepared blank
at 510 nm using a spectrophotometer in comparison with the stan-
dards prepared similarly with known (+)-catechin concentrations.
The results were expressed as mg/g of catechin equivalent.
(c) The antioxidant capacities were determined by ABTS
+ radical
using K2S2O8 and MnO2:
(1) 2, 20-azino-bis (3-ethyl-benzothiazoline-6-sulfonic acid) diamonium
salt (ABTS
+) radical cation was generated by the interaction of
ABTS (250 lM) and K2S2O8 (40 lM). After addition of 990 lL
of ABTS
+ solution to 10 lL of beer or plasma or Trolox (ﬁnal con-
centration 0–20 lM) in phosphate buﬀered saline (PBS), the absor-
bance was monitored exactly 1 and 6 min after the initial mixing
(Miller et al., 1996).
(2) ABTS
+ was prepared as well by passing a 5 mM aqueous stock
solution of ABTS through manganese dioxide on a Whatman no.
5 ﬁlter paper. Excess manganese dioxide was removed from the ﬁl-
trate by passing it through a 0.2 lM Whatman PVDF syringe ﬁlter.
This solution was then diluted in a 5 mM phosphate buﬀered sal-
ine, pH 7.4 to an absorbance of 0.70. The percentage decrease of
the absorbance at 734 nm in (1) and (2) was calculated and plotted
as a function of the concentration of the samples and of Trolox for
the standard reference data and expressed as nM(TE) Trolox
equivalent/g (Miller et al., 1996).
2.4. Animals
All procedures used in the present research were in compliance with
KBN Animal Care Committee guidelines.
Thirty two adult male, 14-week old spontaneously hypertensive rats
(SHR) and normotensive Wistar Kyoto (WKY) rats were used. The rats
were maintained in an air-conditioned room at 21–22  C, with a 12 h
light–dark cycle. Standard pellet food (Labofeed-H) and tap water were
available ad libitum throughout the experiment.
2.5. Experimental procedures
The animals were divided into four groups of 8, two experimental and
two controls, which were named LBWKY and LBSHR and ControlWKY
and ControlSHR, respectively. Lyophilized beer was given to the rats of
the LBWKY and LBSHR groups intragastrically at a dose of 2.72 g/kg in
a volume of 10 ml/kg for 10 days. The rats of the control groups received
saline solution.
In both strains of rats, blood pressure and heart rate were recorded
24 h before the completion of the experiment. Systolic blood pressure (BP)
was measured by tail cuﬀ plethysmography with a photoelectric system
(IITC/Life Sci. Instr. Mod.179, Woodland Hills, CA, USA). A mean value
from at least four consecutive readings was used for calculations. Heart
rate (HR) was counted from the blood pressure pulse wave. On the last
day of study, the animals were sacriﬁced by decapitation and discrete
brain structures taken for the GABA content determination.
Z. Jastrze ˛bski et al. / Food and Chemical Toxicology 45 (2007) 296–302 2972.6. Biochemical studies
The brain GABA accumulation was determined using the GABA-T
inhibition method of Lo ¨scher et al., 1996. To prevent a post-mortem
increase in GABA content, the rats used for the determination of GABA
were injected with 3-mercaptopropionic acid (100 mg/kg, 2.5 min before
killing) according to Carmona et al., 1980. Then, the rats received
aminooxyacetic acid intraperitoneally at a dose of 50 mg/kg, 60 min
before decapitation according to Lo ¨scher et al., 1991. The brains were
quickly removed and dissected on ice-cold Petri dishes. The hypothalamus
and the pons-medulla were isolated according to Balcom et al., 1975.
Tissues were homogenized in a Potter–Elvehjem homogenizer and cen-
trifuged (20 min, 8000·g,4  C). The clear supernatants were stored at
 80  C until assayed. The GABA concentration was measured spectro-
ﬂuorimetrically (Uchida and O’Brien, 1964). Fluorescence was determined
using a Shimatzu spectroﬂuorometer at 380/450 nm. GABA content was
expressed in lM/g tissue. The detection limit of GABA was 0.1 nM.
2.7. Statistical analysis
The results of the investigation in vitro are given as the means ± SD of
ﬁve measurements When appropriate, diﬀerences were tested by ANOVA.
In the assessment of the antioxidant potential, Spearman correlation
coeﬃcient (R) was used. P-values of <0.05 were considered signiﬁcant.
3. Results
3.1. In vitro
The used beer samples were rich in all bioactive com-
pounds: proteins (Fig. 1A), amino acids (Fig. 1B), and
carbohydrates (Fig. 1C).
The contents of polyphenols, ﬂavonoids (epicatechin
and quercetin) and some hydroxycinnamic phenolic acids
(p-coumaric, gallic and ferulic) in the beer samples are
shown in the Table 1. As can be observed from the table,
these beer samples were also rich in the mentioned bioac-
tive compounds.
Table 2 reﬂects the changes in the antioxidant potential
of the beer samples after lyophilization as determined by
with K2S2O8 and MnO2 tests. The decrease in the antioxi-
dant potential of the lyophilized beer samples was not sig-
niﬁcant (P > 0.05). Therefore, the contribution of ethanol
to the antioxidant potential of beer was minimal (R
2 from
0.35 to 0.39).
3.2. In vivo
Weight gains, food consumption and feed eﬃciency
ratio in all 4 groups are summarized in Table 3. The data
show that body weight gain slowed down signiﬁcantly in
rats receiving lyophilized beer (LBSHR and LBWKY).
The dynamics of the blood pressure and heart rate
changes are presented in Fig. 2. A progressive increase in
the blood pressure of SHRs was observed. The treatment
with lyophilized beer did not aﬀect this phenomenon. There
were also no signiﬁcant alterations in the heart rate. Like-
wise, the treatment of normotensive rats (LBWKY) with
lyophilized beer had no eﬀect on their BP and HR.
The inﬂuence of the diﬀerent diet treatments on the
GABA accumulation induced by aminooxyacetic acid
(AOAA) in the hypothalamus and the pons-medulla is
depicted in Fig. 3. The administration of lyophilized beer
decreased the GABA accumulation in the brain of SHR
as well as WKY rats. The results suggest signiﬁcant reduc-
tions in the GABA turnover rate in these two brain areas
following lyophilized beer treatment. The GABA content
in the hypothalamus and the pons-medulla was diminished
in comparison with WKY rats (Fig. 3).
Fig. 1. Composition of the used beer samples: (A) Proteins. Abbrevia-
tions: Tot prot: total proteins; other prot: other proteins; concentration in
g/g lyophilized sample. (B) Essential amino acids. Abbreviations: Val:
valine; Meth: methionine; Isoleu: isoleucine; Leu: leucine; Phen: phenyl-
alanine; Hist: histidine; Lys: lysine; Arg: arginine; Tryp: tryptophan; Thr:
threonine; concentration in mg/g lyophilized sample. (C) Carbohydrates
and sugars. Abbreviations: Tot sug: total sugars; red sug: reducing sugars;
maltotri: maltotriose; concentration in g/g lyophilized sample.
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The circumstantial evidence, which links alcohol con-
sumption with blood pressure is well documented (Klatsky
et al., 1977). A large cross-sectional population study
involving 86000 males and females demonstrated no diﬀer-
ences in blood pressure in males drinking one or two alco-
holic drinks per day. However, in females both systolic and
diastolic blood pressures were lower in light drinkers com-
pared with no drinkers (Klatsky et al., 1977). Some other
studies also found such J- or U-shaped associations
(Harburg et al., 1980). In addition, clinical studies gave
supportive evidence for a pressor eﬀect of alcohol. So, in
one of the investigations hypertensive males who regularly
drank up to eight drinks daily were admitted to hospital
(Potter and Beevers, 1984). After admission, alcohol was
withdrawn for 3–4 days and the blood pressure fell, but
increased again after alcohol was reintroduced.
According to Vandongen and Puddey, 1994, ethanol
rather than the type of beverage is the factor associated
with blood pressure. However, it was shown that not only
the ethanol content of alcoholic beverages is a biologically
active factor, the dry matter of wine and beer may be also
bioactive (Gorinstein et al., 1998a; Gorinstein et al.,
1998b). Therefore, in the present study, we aimed to
explore the possible association between intake of the beer
dry matter and blood pressure. To the best of our knowl-
edge, there have been no similar investigations done so far.
In our in vitro investigation we found that the lyophi-
lized beer samples were rich in proteins, amino acids, and
carbohydrates. Also the contents of polyphenols, ﬂavo-
noids, and some phenolic acids in the used beer samples
were high. These data are in accordance with other reports
(Innes, 1998).
It should to be stressed that the antioxidant potential of
the lyophilized beer samples was very high and the diﬀer-
ence between antioxidant potential of lyophilized and not
lyophilized beer samples was not signiﬁcant. Thus, the con-
tribution of ethanol to the beer antioxidant potential can
be neglected. Also these data are in accordance with our
Table 1
Total polyphenols, ﬂavonoids and some phenolic acids in used beer
samples
Components Concentration (mg/g)
Total polyphenols 9.33 ± 0.33
Flavonoids 1.40 ± 0.11
Epicatechin 1.77 ± 0.09
Quercetin 0.03 ± 0.01
p-Coumaric acid 0.06 ± 0.02
Gallic acid 0.08 ± 0.03
Ferulic acid 0.18 ± 0.12
Procyanidins 1.68 ± 0.11
Values are means ± SD of 5 measurements.
Table 2
Changes in the antioxidant potential of the used beer samples after
lyophilization as determined by K2S2O8 and MnO2 tests (nM TE/g)
Samples K2S2O8 MnO2
Before lyophilization 49.46 ± 3.1
a 56.49 ± 4.6
a
After lyophilization 48.11 ± 3.4
a 53.51 ± 4.2
a
Values are means ± SD of 5 measurements. Values in columns with dif-
ferent superscript letters diﬀer signiﬁcantly (P < 0.05).
Table 3
Body weight gains (g) in all 4 groups.
Groups Weight gains (on
the third day)
Weight gains (on
the sixth day)
Weight gains (on
the ninth day)
LBSHR 6.0 ± 0.3
b 6.0 ± 0.3
b 6.0 ± 0.3
a
ControlSHR 11.0 ± 0.7
c 13.0 ± 0.8
c 15.0 ± 0.9
b
LBWKY 0.1 ± 0.01
a 1.0 ± 0.1
a 4.0 ± 0.2
a
ControlWKY 0.2 ± 0.02
a 10.0 ± 0.6
c 12.0 ± 0.7
b
Values are means ± SD (n = 8).
Means in columns with diﬀerent superscript letters are signiﬁcantly dif-
ferent (P < 0.05).
Abbreviations: ControlWKY, control group of normotensive rats; Con-
trolSHR, control group of hypertensive rats; LBWKY, experimental
group of normotensive rats; LBSHR, experimental group of hypertensive
rats.
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Fig. 2. Eﬀect of lyophilized beer (LB) on blood pressure (BP) and heart
rate (HR) in WKY and SHR rats (n = 8).
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et al., 1998a; Gorinstein et al., 1998b; Carbonneau et al.,
1998; Seraﬁni et al., 1998).
The results of the investigation in vivo indicated that
GABA content and consequently its turnover in the brain
structures involved in blood pressure control i.e. the hypo-
thalamus and the pons-medulla were lower in SHR than in
WKY rats. It is in line with the outcomes of our previous
studies and those of others who proved that the central
GABAergic system in spontaneously hypertensive rats is
impaired and its chronic inhibition may increase sympa-
thetic overactivity (Czy_ zewska-Szafran et al., 1989;
Czy_ zewska-Szafran et al., 1991; Singewald et al., 1992; Ich-
ida et al., 1996).
Our present ﬁndings revealed that administration of
lyophilized beer did not aﬀect the established hypertension
characteristic of the SHR strain. Similarly, LB was shown
to have no inﬂuence on cardiovascular function in normo-
tensive WKY rats. AOAA is an inhibitor of GABA-trans-
aminase, the enzyme responsible for the GABA catabolism
in the brain. AOAA signiﬁcantly increases the intracellular
GABA content in all brain regions. AOAA has an inherent
action. The substance is commonly used in the experiments
to estimate the GABA concentration and turnover rate in
particular brain structures and thus to characterize the
GABAergic tone of the concerned brain areas. The aim
of our study was to explore the eﬀect of LB on the GAB-
Aergic function in the brain structures involved in cardio-
vascular control. For that purpose it was suﬃcient to
compare only two experimental groups of each rat strain:
AOAA-injected animals with AOAA-injected and addi-
tionally LB-receiving animals.
Furthermore, this study provided evidence that the
treatment of SHR and WKY rats with LB caused marked
reduction in the AOAA-induced GABA accumulation in
the brain structures mentioned above suggesting suppres-
sion of the central GABAergic activity.
Recently, a number of reports demonstrated that certain
neurosteroids synthesized in the brain can modulate the
inhibitory action of GABAA receptor (Robel and Baulieu,
1995; Barbaccia et al., 1997; Morrow et al., 1999). On the
other hand, the inhibition of steroid synthesis was shown
to prevent completely the inhibitory eﬀects of alcohol asso-
ciated with GABAA receptor modulation (VanDoren et al.,
2000). Therefore, it seems very likely that cholesterol, as a
known precursor of all neurosteroids synthesis may indi-
rectly inﬂuence the GABAA receptor function (Papadopo-
ulos et al., 1992).
In our previous studies on rats fed with lyophilized beer,
we observed signiﬁcant reduction of plasma total choles-
terol level (Gorinstein et al., 1998a; Gorinstein et al.,
1998b). It is possible that the lowered cholesterol concen-
tration in the blood of the LB-treated rats contributes to
the changes in the brain GABA accumulation observed
in our study.
The results of the present study showed that there exists
a clear association between the brain GABA accumulation
and turnover, and the diet supplemented with lyophilized
beer having no impact on cardiovascular function. It might
be, however, that prolonged treatment with LB would
intensify arterial blood pressure as a result of the perma-
nent GABA system suppression. Therefore, further studies
with a long term LB intake are needed to conﬁrm the lack
of the haemodynamic eﬀects of LB, despite the marked
attenuation of the central GABAergic activity.
At this stage of surveys, it is diﬃcult to explain the
mechanism responsible for the reduction of the body
weight gains in LB-treated rats as compared with their
corresponding controls. However, our results are consis-
tent with those of other authors who report that beer
intake is inversely associated with the body mass index in
men and women and that alcohol beverage consumers
are leaner than abstainers (Kahn et al., 1997; Ma ¨nnisto ¨
et al., 1997; Dallongeville et al., 1998). It is conceivable,
that the impared GABAergic inhibition observed in this
study produces alterations in sympathetic activity of
importance for energy turnover and motor function. The
regulation of body weight via regulation of sympathetic
outﬂow is suggested in a number of reports (Eslami and
Tuck, 2003; Nagai and Moritani, 2004; Hegling et al.,
2005). In such case lyophilized beer owing to its inﬂuence
Fig. 3. Eﬀect of lyophilized beer (LB) on GABA accumulation in the
hypothalamus (hypothal) and the pons-medulla (pons-med) induced by
aminooxyacetic acid (AOAA). (n = 8). P < 0.01, P < 0.001 versus AOAA
group.
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sympathetic regulation could be eﬀective for body mass
reduction.
AtthebeginningweexpectedthatLBwillpositivelyinﬂu-
enceBPandHRbymeansoftheGABAcontentelevationin
the brain areas related to cardiovascular control. It was not
thecaseandtheGABAcontentwasloweredinthoseareasas
compared with AOAA-alone group. Normally, the reduc-
tion of central GABA content should result in BP elevation.
Surprisingly, we noted that under the experimental condi-
tions applied LB did not exert any deleterious eﬀect on car-
diovascular function in both rat strains having reducing
inﬂuence on their weight gains. Therefore, our results indi-
cated that LB has potent biological activity and can be safe
ingested by both hypertensive and normotensive objects.
The weight gain reducing action may have additional bene-
ﬁcial eﬀect for the treatment of obesity which is often
connected with hypertension. However, to clear the signiﬁ-
canceoftheseobservationfortheputativefuturealimentary
therapy further intensive studies with prolonged LB admin-
istration and diverse dosing will be needed.
In conclusion, lyophilized beer contains high quantities
of bioactive compounds and exhibits a high antioxidant
potential. A diet supplemented with lyophilized beer causes
signiﬁcant reduction of central GABAergic activity in
normotensive and hypertensive rats without any eﬀect on
cardiovascular function. In addition, in both animal strains
there exists an inverse association between lyophilized beer
intake and body weight gain.
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